2013Chinese Journal of New Clinical MedicineRequires access

Comparison of the efficacy between pioglitazone and metformin in the treatment of patients with type 2 diabetes patients

Dechen Zhang

Open publisher page 0 citations

Abstract

Objective To compare the efficacy between pioglitazone and metformin in the treatment of patients with type 2 diabetes.Methods Ninety-six petients with type 2 diabetes were divided into a control group and a treatment group based on treatment order,each group had 48 patients.The control group were treated with metformin;the treatment group were treated with pioglitazone.One month after treatment,the control conditions of blood glucose were compared between two groups.Results After one month of the medication,the total effective rate of control group was 87.5%(42/48),that of the treatment group was 89.6%(43/48),there was no statistically significant difference between two groups(P0.05).In treatment group,the fasting plasma glucose and 2 h postprandial blood sugar level improved slightly larger than the control group(P0.05);the incidence of adverse reactions of the control group was more than that of treatment group(P0.01).Conclusion Metformin,pioglitazone can effectively control blood glucose of patients with type 2 diabetes.

About this research paper

What this paper is about

Objective To compare the efficacy between pioglitazone and metformin in the treatment of patients with type 2 diabetes.Methods Ninety-six petients with type 2 diabetes were divided into a control group and a treatment group based on treatment order,each group had 48 patients.The control group were treated with metformin;the treatment group were treated with pioglitazone.One month after treatment,the control conditions of blood glucose were compared between two groups.Results After one month of the medication,the total effective rate of control group was 87.5%(42/48),that of the treatment group was 89.6%(43/48),there was no statistically significant difference between two groups(P0.05).In treatment group,the fasting plasma glucose and 2 h postprandial blood sugar level improved slightly larger than the control group(P0.05);the incidence of adverse reactions of the control group was more than that of treatment group(P0.01).Conclusion Metformin,pioglitazone can effectively control blood glucose of patients with type 2 diabetes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy between pioglitazone and metformin in the treatment of patients with type 2 diabetes.Methods Ninety-six petients with type 2 diabetes were divided into a control group and a treatment group based on treatment order,each group had 48 patients.The control group were treated with metformin;the treatment group were treated with pioglitazone.One month after treatment,the control conditions of blood glucose were compared between two groups.Results After one month of the medication,the total effective rate of control group was 87.5%(42/48),that of the treatment group was 89.6%(43/48),there was no statistically significant difference between two groups(P0.05).In treatment group,the fasting plasma glucose and 2 h postprandial blood sugar level improved slightly larger than the control group(P0.05);the incidence of adverse reactions of the control group was more than that of treatment group(P0.01).Conclusion Metformin,pioglitazone can effectively control blood glucose of patients with type 2 diabetes.

Key concepts: Medicine, Pioglitazone, Metformin, Postprandial, Type 2 diabetes, Blood sugar, Internal medicine, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of the efficacy between pioglitazone and metformin in the treatment of patients with type 2 diabetes patients — Research Paper | ScholarLens